Liquid Grids competitors
Liquid Grids Competitors include Keryx Biopharmaceuticals, NovaBay Pharmaceuticals, Chiasma and LGC Biosearch Technologies.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Liquid Grids Liquid Grids empowers healthcare companies to listen, understand, and strategically engage in online health dialogues. |  Keryx Biopharmaceuticals Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases. |  NovaBay Pharmaceuticals NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market. |  Chiasma Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases. |  LGC Biosearch Technologies LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
|
Founding Date | Founding Date 2010 | Founding Date 1998 | Founding Date 2000 | Founding Date 2001 | Founding Date 1842 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations New York, US HQ Boston, US | Locations Emeryville, US HQ | Locations Waltham, US HQ Ness Ziona, IL | Locations Teddington, GB HQ |
Employees | Employees 913% increase | Employees N/A | Employees 21 | Employees 16 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 26.5 m | Valuation ($) 94.5 m | Valuation ($) N/A |
Twitter followers | Twitter followers 1.4 k | Twitter followers 391 | Twitter followers 2.2 k | Twitter followers 42 | Twitter followers 2.4 k |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $60.6m (FY, 2017) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £131.2m (FY, 2018) |
Net income | Net income N/A | Net income ($163.4m) (FY, 2017) | Net income N/A | Net income ($26.8m) (FY, 2017) | Net income £9.2m (FY, 2018) |
Funding | |||||
Total funding raised | Total funding raised $ 5.5m | Total funding raised N/A | Total funding raised $ 13.6m | Total funding raised $ 139.8m | Total funding raised N/A |
For sources of this data, please see the company profileDownload Excel
View company profiles
Keryx Biopharmaceuticals
HQ
New York, US
Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.
View companyNovaBay Pharmaceuticals
HQ
Emeryville, US
Employees
21
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
View companyChiasma
HQ
Waltham, US
Employees
16
Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.
View companyLGC Biosearch Technologies
HQ
Teddington, GB
LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
View company